| Literature DB >> 26413287 |
Doris T Chan1, Rose Faratro2, Christopher T Chan2.
Abstract
BACKGROUND: Simulation has been associated with positive educational benefits in the training of healthcare professionals. It is unknown whether the use of simulation to supplement patient training for home hemodialysis (HHD) will assist in improving a patient's transition to home. We aim to assess the impact of simulation training on home visits, retraining and technique failure.Entities:
Keywords: home hemodialysis; patient training; simulation teaching
Year: 2015 PMID: 26413287 PMCID: PMC4581385 DOI: 10.1093/ckj/sfv067
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
Fig. 1.Patient flow chart.
Patient characteristics
| Case ( | Control ( | P-value | |
|---|---|---|---|
| Age at training (years) | 44.5 (17) | 40.0 (32) | 0.73 |
| Males, | 16 (57.1) | 12 (57.1) | 0.62 |
| Race, | |||
| Caucasian | 9 (32.1) | 9 (42.9) | 0.43 |
| Asian | 8 (28.6) | 3 (14.3) | |
| Black | 4 (14.3) | 3 (14.3) | |
| Indian subcontinent | 6 (21.4) | 4 (19.0) | |
| Mid-east/Arabian | 1 (3.6) | 0 (0) | |
| Latin American | 0 (0) | 2 (9.5) | |
| Body mass index (kg/m2) | 24.9 (13.0) | 23.9 (6.8) | 0.12 |
| Cause of ESRD, | |||
| Glomerulonephritis | 11 (39.3) | 5 (23.8) | 0.48 |
| Diabetes | 4 (14.3) | 4 (19.0) | |
| Hypertension | 2 (7.1) | 0 (0) | |
| Others | 9 (32.1) | 9 (42.9) | |
| Unknown | 2 (7.1) | 3 (14.3) | |
| Presence of permanent access during training (AVF or AVG), | 16 (57.1) | 6 (28.6) | 0.04 |
| Duration of RRT prior to home HD training (weeks) | 46.5 (767.5) | 4.1 (93.4) | 0.28 |
| Days in the Innovation Room (days) | 2 (1.75) | — | — |
| Duration of follow-up (months) | 12.1 (10.5) | 9.4 (9.9) | 0.93 |
| Training duration (weeks) | 10.0 (6.0) | 11.0 (4.0) | 0.15 |
Data presented as median (IQR) and comparison by Mann–Whitney for continuous variables. For categorical variables, data is presented as numbers (percentage) and comparison by Chi-squared or Fisher exact test.
AVF, arteriovenous fistula; AVG, arteriovenous graft; RRT, renal replacement therapy.
Patient comorbidities and social situations
| Case ( | Control ( | P-value | |
|---|---|---|---|
| Presence of diabetes, | 8 (28.6) | 6 (28.6.0) | 0.62 |
| Presence of CHD, | 1 (3.6) | 3 (14.3) | 0.20 |
| Presence of COAD, | 1 (3.6) | 1 (4.8) | 0.70 |
| Previous renal transplant, | 10 (35.7) | 6 (25.0) | 0.30 |
| Smoking status, | |||
| Never smoked | 24 (85.7) | 15 (71.4) | 0.08 |
| Ex-smoker | 2 (7.1) | 6 (28.6) | |
| Current smoker | 2 (7.1) | 0 (0) | |
| Charlson Comorbidity index | 3.0 (3.0) | 3.0 (3.5) | 0.80 |
| Present with training partner, | 5 (17.9) | 3 (14.3) | 0.53 |
| Percent with own home, | 25 (89.3) | 17 (81.0) | 0.34 |
| Percent unemployed, | 14 (50.0) | 9 (42.9) | 0.42 |
| Percent home alone, | 3 (10.7) | 2 (9.5) | 0.64 |
Data presented as median (IQR) and comparison by Mann–Whitney for continuous variables. For categorical variables, data is presented as numbers (percentage) and comparison by Chi-squared or Fisher exact test.
CHD, coronary heart disease; COAD, chronic obstructive airways disease.
Effect of exposure to the innovation room on outcomes
| Case ( | Control ( | P-value | |
|---|---|---|---|
| Number of home visits ( | 1.0 (1.0) | 2.0 (2.0) | 0.058 |
| Number of retraining sessions ( | 0.0 (1.8) | 0.0 (4.5) | 0.84 |
| Proportion with technique failure, | 0 (0) | 1 (3.6) | 0.54 |
Data presented as median (IQR) and comparison by Mann–Whitney for continuous variables. For categorical variables, data is presented as numbers (percentage) and comparison by Chi-squared or Fisher exact test.
Effect of the presence of permanent access on outcomes
| Use of permanent access | Yes ( | No ( | P-value |
|---|---|---|---|
| Training duration (weeks) | 11.5 (5.0) | 10.0 (4.0) | 0.26 |
| Number of home visits ( | 1.5 (1.25) | 1.0 (1.0) | 0.78 |
| Number of retraining sessions ( | 0.0 (1.25) | 0.0 (3.0) | 0.55 |
Data presented as median (IQR) and comparison by Mann–Whitney for continuous variables. For categorical variables, data is presented as numbers (percentage) and comparison by Chi-squared or Fisher exact test.